Further Insights on Structural Modifications of Muramyl Dipeptides to Study the Human NOD2 Stimulating Activity

Area of Science:

• Immunology
• Medicinal Chemistry
• Organic Synthesis

Background:

• Muramyl dipeptide (MDP) is a key component of bacterial cell walls.
• MDP interacts with the NOD2 receptor, playing a role in innate immunity.
• Understanding MDP-NOD2 interactions is crucial for developing immunomodulatory therapies.

Purpose of the Study:

• To synthesize and evaluate novel muramyl dipeptide (MDP) analogues.
• To investigate the structure-activity relationship of MDP analogues on human NOD2 stimulation.
• To identify potent NOD2 agonists for potential therapeutic applications.

Main Methods:

• Synthesis of MDP analogues via CuAAC click chemistry for C4 diversification.
• Modification of the d-iso-glutamine residue using esterification and amidation.
• Bio-evaluation of 26 synthesized MDP analogues for human NOD2 stimulation activity.

Main Results:

• MDP analogues with ester moieties exhibited enhanced NOD2 stimulation potency compared to MDP and amide analogues.
• The length of the alkyl chain in ester derivatives influenced NOD2 activation.
• The MDP analogue with a d-glutamate dodecyl (C12) ester showed the highest NOD2 stimulation potency.

Conclusions:

• Structural modifications, particularly esterification at the d-glutamate residue, significantly enhance NOD2 agonist activity.
• The C12 dodecyl ester MDP analogue is a potent NOD2 stimulant.
• These findings provide a basis for designing novel immunomodulatory agents targeting NOD2.